APR 11, 2019 4:24 PM PDT

Drug-resistant Candida Auris is Spreading

WRITTEN BY: Tiffany Dazet

A drug-resistant fungal yeast, Candida auris, is spreading throughout hospitals worldwide. Deemed “an urgent threat” by the Center for Disease Control and Prevention (CDC), C. auris has infected more than 600 people in the United States as of March 29, 2019. Most of these cases were reported in the New York City, New Jersey, and Chicago areas. Cases of C. auris infections have been reported from multiple countries including Australia, China, France, Germany, India, Russia, Pakistan, and many more. It’s suspected that some of the cases in the U.S. came from patients who had recent stays in healthcare facilities in select countries abroad.

The first official case of C. auris was reported in Japan in 2009. According to the CDC, C. auris is resistant to multiple antifungal drugs that are commonly used to treat Candida infections making infections difficult to treat and deadly. The CDC estimates that more than 90% of C. auris infections are resistant to at least one type of drug, while 30% are resistant to two or more drugs. 

While drug-resistant microbes aren’t unheard of, the way that C. auris is transmitted was shocking to medical providers. Typical Candida infections don’t spread from patient to patient; however, C. auris was found to remain on skin and surfaces for extensive periods of time. Extreme precautions must be taken to prevent the spread of the infection, and once exposed hospital rooms and equipment must be thoroughly cleaned and disinfected with specific materials recommended by the CDC. 

The rise of C. auris infections has been seen in healthcare settings, due to the reasons listed above. In addition to its resistant to anti-fungal drugs and transmission, it impacts those with weakened immune systems and infections are commonly reported in wounds, bloodstreams, and ears. A study published last year in Emerging Infectious Diseases documented how deadly and invasive C. auris can be in a healthcare setting. Of 51 cases in New York from 2016 to 2018, nearly half of the patients died within 90 days of being diagnosed with C. auris infections. The threat of C. auris infecting healthy individuals is very low.

Sources: The New York Times, Forbes, CDC
 

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
JUN 11, 2020
Cell & Molecular Biology
JUN 11, 2020
Changes in Gut Mucus are Connected to Brain Disorders
In recent years, researchers have learned more about how important the gut is to human health. Trillions of microbes liv ...
JUN 22, 2020
Genetics & Genomics
JUN 22, 2020
People That Acquire Genetic Mutations Faster May Not Live as Long
Every cell in our boy carries a copy of the genome in its nucleus. Some cells are constantly replenished, and the genome ...
JUN 22, 2020
Earth & The Environment
JUN 22, 2020
Half of the global population is exposed to air pollution
A World Health Organization study published recently in the journal Climate and Atmospheric Science reports that half of ...
JUN 30, 2020
Cardiology
JUN 30, 2020
Investigating How Aging Affects Cardiac Health in Marmosets
Age is something that scientists still struggle to understand. It seems to be built into the DNA and affects the human b ...
JUL 05, 2020
Cell & Molecular Biology
JUL 05, 2020
COVID-19 Attacks Endothelial Cells
The pandemic virus SARS-CoV-2 enters the body through the respiratory system to cause the illness COVID-19. But we know ...
JUL 08, 2020
Cancer
JUL 08, 2020
Tracking Down Biomarkers for Bladder Cancer Using Mass Spectrometry
Bladder cancer is one of the most common cancers in the world. Non-muscle invasive bladder cancer (NMIBC) is a precursor ...
Loading Comments...